Participants
The parents of 45 consecutive children with solid and haematological tumors treated in the Pediatric Oncology, Pediatric Neurosurgery, and Radiotherapy Unit of Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome were enrolled in the study. Criteria for selecting the subjects were: 1) parent of a patient with a cancer diagnosis; 2) parent of a patient who was in treatment or had completed their treatment regimen; and 3) parent of patients < 25 years of age. Parents with psychiatric or cognitive disorders or intellectual disability were excluded from the study.
This study was performed in accordance with the Helsinki declaration and approved by the Institutional Review Board. Written informed consent was obtained from all participants.